Literature DB >> 10376735

Localization and expression of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage.

P E Di Cesare1, C Fang, M P Leslie, C J Della Valle, J M Gold, H Tulli, R Perris, C S Carlson.   

Abstract

Synovium and cartilage from patients with osteoarthritis or rheumatoid arthritis were analyzed for expression of cartilage oligomeric matrix protein. Immunostaining of synovium with antiserum to cartilage oligomeric matrix protein demonstrated positive staining in both diseases. In osteoarthritis, there was positive staining within the synovial cells and immediately subjacent connective tissue, with less intense staining in the deeper connective tissue. In rheumatoid arthritis, there was less intense staining within the synovial cells and marked intense staining in the deeper connective tissue. In situ hybridization performed with an antisense digoxigenin-labeled riboprobe to human cartilage oligomeric matrix protein confirmed the presence of cartilage oligomeric matrix protein mRNA in the cells of the synovial lining in both types of synovium. Quantitative polymerase chain reaction with a cartilage oligomeric matrix protein MIMIC demonstrated increased cartilage oligomeric matrix protein mRNA in rheumatoid cartilage and synovium as compared with osteoarthritic cartilage and synovium, respectively; mRNA levels in rheumatoid synovium were similar to those from osteoarthritic chondrocytes. As a result of the high expression of cartilage oligomeric matrix protein from rheumatoid synovium, inflammatory synovium should be considered as a potential tissue source of cartilage oligomeric matrix protein in any investigation of biological markers of cartilage metabolism. The upregulated expression of cartilage oligomeric matrix protein in inflammatory tissues suggests its in vivo regulation by cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376735     DOI: 10.1002/jor.1100170321

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  10 in total

1.  Identification of a 3Kbp mechanoresponsive promoter region in the human cartilage oligomeric matrix protein gene.

Authors:  Derek F Amanatullah; Jeffrey Lu; Jacqueline Hecht; Karen Posey; Jasper Yik; Paul E Di Cesare; Dominik R Haudenschild
Journal:  Tissue Eng Part A       Date:  2012-08-10       Impact factor: 3.845

2.  Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth.

Authors:  Li Kong; Qingyun Tian; Fengjin Guo; Maria T Mucignat; Roberto Perris; Sandy Sercu; Joseph Merregaert; Paul E Di Cesare; Chuan-Ju Liu
Journal:  Matrix Biol       Date:  2010-02-04       Impact factor: 11.583

3.  ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein.

Authors:  Chuan-ju Liu; Wei Kong; Ke Xu; Yi Luan; Kiril Ilalov; Bantoo Sehgal; Shuang Yu; Ronald D Howell; Paul E Di Cesare
Journal:  J Biol Chem       Date:  2006-04-12       Impact factor: 5.157

4.  ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.

Authors:  Chuan-Ju Liu; Wei Kong; Kiril Ilalov; Shuang Yu; Ke Xu; Lisa Prazak; Marc Fajardo; Bantoo Sehgal; Paul E Di Cesare
Journal:  FASEB J       Date:  2006-04-03       Impact factor: 5.191

5.  Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin.

Authors:  Y Luan; L Kong; D R Howell; K Ilalov; M Fajardo; X-H Bai; P E Di Cesare; M B Goldring; S B Abramson; C-J Liu
Journal:  Osteoarthritis Cartilage       Date:  2008-05-15       Impact factor: 6.576

6.  ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor.

Authors:  Xiao-Hui Bai; Da-Wei Wang; Li Kong; Yan Zhang; Yi Luan; Tatsuya Kobayashi; Henry M Kronenberg; Xiu-Ping Yu; Chuan-Ju Liu
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

7.  Mechanical and biochemical characterization of cartilage explants in serum-free culture.

Authors:  L Bian; E G Lima; S L Angione; K W Ng; D Y Williams; D Xu; A M Stoker; J L Cook; G A Ateshian; C T Hung
Journal:  J Biomech       Date:  2008       Impact factor: 2.712

8.  Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Authors:  L A Joosten; E Lubberts; M M Helsen; T Saxne; C J Coenen-de Roo ; D Heinegård; W B van den Berg
Journal:  Arthritis Res       Date:  1999-10-26

Review 9.  Cellular and molecular meniscal changes in the degenerative knee: a review.

Authors:  Mariano López-Franco; Enrique Gómez-Barrena
Journal:  J Exp Orthop       Date:  2018-04-19

10.  Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.

Authors:  Martin Skoumal; Günther Haberhauer; Josef Feyertag; Eva Maria Kittl; Kurt Bauer; Attila Dunky
Journal:  Arthritis Res Ther       Date:  2004-03-08       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.